Document ID: chunk:federal_register_of_legislation:F2024C01086:schedule:1:p2
Version: federal_register_of_legislation:F2024C01086
Segment Type: schedule
Provision Reference: sch 1 (pt 2/3)
Character Range: 821704–824426

a menstrual cycle of the patient; and
 (b) ends:
 (i) if a service described in item 13212, 13215 or 13221 is provided in connection with the series of treatments—on the day after the day on which the last of those services is provided; or
 (ii) in any other case—not more than 30 days after the day mentioned in subparagraph (a)(i) or (ii).

5.2.4  Items provided as part of treatment cycle relating to assisted reproductive services not to apply
 (1) This clause applies if:
 (a) a service to which an item (the first item) in Subgroup 3 of Group T1 applies is provided to a patient during a treatment cycle; and
 (b) a service described in an item (the second item) (other than an item in Subgroup 3 of Group T1 or item 73384, 73385, 73386 or 73387 of the pathology services table) is provided to the patient during the same treatment cycle; and
 (c) the service described in the second item is associated with the service to which the first item applies.
 (2) The second item does not apply to the service described in that item.

5.2.5  Restriction on item 13104—timing
  Item 13104 does not apply to a patient more than 12 times in a 12 month period.

5.2.6  Restriction on items relating to assisted reproductive services—certain pregnancy‑related circumstances
  Items 13200 to 13221 do not apply to a service provided in relation to a patient's pregnancy, or intended pregnancy, that is, at the time of the service, the subject of an agreement, or arrangement, under which the patient makes provision for transfer to another person of the guardianship of, or custodial rights to, a child born as a result of the pregnancy.

5.2.6A  Restriction on items 14217 and 14220—maintenance therapy
  A service under item 14217 or 14220 cannot be provided to a patient as maintenance therapy for the prevention of further relapse of the patient's depression.

5.2.7  Restrictions on items 14227 to 14237—patients
  Items 14227 to 14237 apply to a service in relation to a patient only if:
 (a) the patient has:
 (i) chronic spasticity of cerebral origin; or
 (ii) chronic spasticity caused by multiple sclerosis, spinal cord injury or spinal cord disease; and
 (b) oral antispastic agents have failed or have caused the patient to experience unacceptable side effects; and
 (c) an authority has been given by the Chief Executive Medicare to provide the service to the patient.

5.2.8  Restrictions on item 14245—practitioner and timing
 (1) Item 14245 applies only to a service provided by a medical practitioner who is registered by the Chief Executive Medicare to participate in the arrangements made, under paragraph 100(1)(b) of the National Health Act 1953, for providing an adequate pharmaceutical service for persons